Oncolytics Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ONCY and other ETFs, options, and stocks.

About ONCY

Oncolytics Biotech, Inc. engages in the provision of development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolation of the reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. 

CEO
Jared Kelly
CEOJared Kelly
Employees
29
Employees29
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1998
Founded1998
Employees
29
Employees29

ONCY Key Statistics

Market cap
96.72M
Market cap96.72M
Price-Earnings ratio
-3.23
Price-Earnings ratio-3.23
Dividend yield
Dividend yield
Average volume
2.07M
Average volume2.07M
High today
$0.848
High today$0.848
Low today
$0.8095
Low today$0.8095
Open price
$0.83
Open price$0.83
Volume
827.60K
Volume827.60K
52 Week high
$1.51
52 Week high$1.51
52 Week low
$0.77
52 Week low$0.77

Stock Snapshot

Oncolytics Biotech(ONCY) stock is priced at $0.82, giving the company a market capitalization of 96.72M. It carries a P/E multiple of -3.23.

As of 2026-07-25, Oncolytics Biotech(ONCY) stock has fluctuated between $0.81 and $0.85. The current price stands at $0.82, placing the stock +1.2% above today's low and -3.4% off the high.

The Oncolytics Biotech(ONCY)'s current trading volume is 827.6K, compared to an average daily volume of 2.07M.

In the last year, Oncolytics Biotech(ONCY) shares hit a 52-week high of $1.51 and a 52-week low of $0.77.

In the last year, Oncolytics Biotech(ONCY) shares hit a 52-week high of $1.51 and a 52-week low of $0.77.

ONCY News

TipRanks 17h
Oncolytics Biotech Faces Nasdaq Minimum Bid Price Noncompliance

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

Barchart 5d
Stocks in play: Oncolytics Biotech Inc - Barchart.com

...

Stocks in play: Oncolytics Biotech Inc - Barchart.com
TipRanks 5d
Oncolytics announces FDA Fast Track designation for pelareorep

Oncolytics (ONCY) announced that the FDA has granted Fast Track designation to pelareorep in combination with a checkpoint inhibitor for the treatment of patien...

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

People also own

Based on the portfolios of people who own ONCY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.